Ken Fujioka Selected Research

Ken Fujioka Research Topics

Disease

33	Weight Loss (Weight Reduction) 04/2021 - 07/2002
22	Obesity 04/2021 - 12/2002
12	Body Weight (Weight, Body) 01/2021 - 07/2002
12	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2003
8	Overweight 01/2019 - 12/2002
5	Nausea 11/2017 - 08/2007
4	Short Bowel Syndrome 08/2018 - 02/2016
3	Prediabetic State (Prediabetes) 01/2019 - 11/2016
3	Intestinal Failure 08/2018 - 02/2016
3	Vomiting 11/2017 - 08/2010
3	Abdominal Pain (Pain, Abdominal) 11/2017 - 09/2014
3	Morbid Obesity 09/2014 - 02/2005
3	Insulin Resistance 09/2011 - 07/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2021 - 09/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2006 - 01/2006
1	Fibrosis (Cirrhosis) 04/2021
1	Bulimia (Binge Eating) 02/2021
1	Stomach Neoplasms (Stomach Cancer) 09/2019
1	Osteoporosis 09/2019
1	Alzheimer Disease (Alzheimer's Disease) 09/2019
1	Sepsis (Septicemia) 02/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Cholecystitis 01/2016
1	Hepatitis 01/2016
1	Hepatitis A (Hepatitis, Infectious) 01/2016
1	Diarrhea 07/2015
1	Human Influenza (Influenza) 01/2015
1	Dyspepsia (Indigestion) 09/2014
1	Heartburn (Pyrosis) 09/2014
1	Inflammation (Inflammations) 09/2011
1	Critical Illness (Critically Ill) 09/2011
1	Headache (Headaches) 08/2010
1	Dizziness (Lightheadedness) 08/2010
1	Constipation 08/2010
1	Binge-Eating Disorder (Binge Eating Disorder) 03/2008
1	Hyperglycemia 12/2007
1	Tachycardia (Tachyarrhythmias) 07/2006

Drug/Important Bio-Agent (IBA)

8	Bupropion (Wellbutrin)FDA LinkGeneric 01/2017 - 07/2002
7	Naltrexone (ReVia)FDA LinkGeneric 01/2017 - 01/2009
5	Liraglutide FDA Link 01/2017 - 07/2015
4	Pharmaceutical PreparationsIBA 04/2021 - 02/2003
4	teduglutideIBA 08/2018 - 02/2016
4	lorcaserinIBA 01/2017 - 11/2013
4	Insulin (Novolin)FDA Link 12/2007 - 02/2003
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2003
3	Phentermine (Adipex-P)FDA LinkGeneric 01/2017 - 11/2013
3	LipidsIBA 12/2013 - 02/2003
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2009 - 01/2009
3	sibutramine (Meridia)FDA Link 12/2006 - 12/2002
2	Metformin (Glucophage)FDA LinkGeneric 04/2021 - 02/2003
2	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2021 - 12/2007
2	HydrogelsIBA 07/2019 - 01/2019
2	Topiramate (Topamax)FDA LinkGeneric 01/2016 - 11/2013
2	Orlistat (Xenical)FDA Link 01/2016 - 12/2002
2	Narcotic Antagonists (Opioid Antagonists)IBA 08/2009 - 01/2009
2	Hormones (Hormone)IBA 12/2007 - 08/2007
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 08/2007 - 12/2002
1	Hemoglobins (Hemoglobin)IBA 02/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	AcetaldehydeIBA 09/2019
1	Narcotics (Narcotic Analgesics)IBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Serum AlbuminIBA 02/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2015
1	salicylhydroxamic acid (SHAM)IBA 09/2014
1	Dihydrotachysterol (AT 10)IBA 09/2014
1	ephedrine drug combination caffeineIBA 10/2013
1	LeptinIBA 10/2013
1	Estrogens (Estrogen)FDA Link 11/2011
1	NitrogenIBA 09/2011
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA 12/2010
1	naltrexone hydrochoride drug combination bupropion hydrochlorideIBA 08/2010
1	Opioid Receptors (Opioid Receptor)IBA 12/2009
1	CosmeticsIBA 04/2009
1	beta-Endorphin (Endorphin, beta)IBA 01/2009
1	MelanocortinsIBA 01/2009
1	IncretinsIBA 12/2007
1	Islet Amyloid PolypeptideIBA 08/2007
1	pramlintide (Symlin)FDA Link 08/2007
1	RimonabantIBA 12/2006
1	trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA 10/2006
1	neuropeptide Y5 receptorIBA 10/2006
1	Triglycerides (Triacylglycerol)IBA 07/2006

Therapy/Procedure

10	Therapeutics 01/2019 - 02/2003
7	Drug Therapy (Chemotherapy) 01/2020 - 12/2006
6	Glycemic Control 02/2021 - 02/2003
5	Bariatric Surgery 04/2021 - 02/2005
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2010 - 03/2008
2	Obesity Management 06/2019 - 11/2013
2	Parenteral Nutrition 08/2018 - 01/2017
1	Catheters 02/2016
1	Nerve Block (Nerve Blocks) 09/2014
1	Critical Care (Surgical Intensive Care) 09/2011
1	Nutrition Therapy (Medical Nutrition Therapy) 09/2011
1	Caloric Restriction 12/2010
1	Aftercare (After-Treatment) 08/2007